Literature DB >> 34389906

The causes and consequences of paediatric kidney disease on adult nephrology care.

Ruth J Pepper1, Richard S Trompeter2.   

Abstract

Adult nephrologists often look after patients who have been diagnosed with kidney disease in childhood. This does present unique challenges to the adult nephrologist, who may be unfamiliar with the underlying cause of kidney disease as well as the complications of chronic kidney disease (CKD) that may have accumulated during childhood. This review discusses common causes of childhood CKD, in particular congenital anomalies of the kidney and urinary tract (CAKUT), autosomal dominant tubulointerstitial kidney disease (ADTKD), polycystic kidney disease, hereditary stone disease, nephrotic syndrome and atypical haemolytic uraemic syndrome. The long-term consequences of childhood CKD, such as the cardiovascular consequences, cognition and education as well as bone health, nutrition and growth are also discussed.
© 2021. IPNA.

Entities:  

Keywords:  CKD; Congenital anomalies of the kidney and urinary tract (CAKUT); Nephrotic; Transition

Mesh:

Year:  2021        PMID: 34389906     DOI: 10.1007/s00467-021-05182-w

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.651


  139 in total

1.  Epidemiology of chronic renal failure in children: data from the ItalKid project.

Authors:  Gianluigi Ardissino; Valeria Daccò; Sara Testa; Roberto Bonaudo; Aldo Claris-Appiani; Emanuela Taioli; Giuseppina Marra; Alberto Edefonti; Fabio Sereni
Journal:  Pediatrics       Date:  2003-04       Impact factor: 7.124

2.  UK Renal Registry 19th Annual Report: Chapter 4 Demography of the UK Paediatric Renal Replacement Therapy Population in 2015.

Authors:  Alexander J Hamilton; Fiona Braddon; Anna Casula; Malcolm Lewis; Tamara Mallett; Stephen D Marks; Mohan Shenoy; Manish D Sinha; Yincent Tse; Heather Maxwell
Journal:  Nephron       Date:  2017-09-29       Impact factor: 2.847

3.  The 21st UK Renal Registry Annual Report: A Summary of Analyses of Paediatric Data in 2017.

Authors:  Lucy Plumb; Anna Casula; Rhodri Pyart; Katharine M Evans; Carol Inward; James Medcalf; Stephen D Marks
Journal:  Nephron       Date:  2019-12-11       Impact factor: 2.847

4.  Changing patterns in the histopathology of idiopathic nephrotic syndrome in children.

Authors:  M Bonilla-Felix; C Parra; T Dajani; M Ferris; R D Swinford; R J Portman; R Verani
Journal:  Kidney Int       Date:  1999-05       Impact factor: 10.612

5.  High incidence of focal segmental glomerulosclerosis in nephrotic syndrome of childhood.

Authors:  T Srivastava; S D Simon; U S Alon
Journal:  Pediatr Nephrol       Date:  1999-01       Impact factor: 3.714

6.  End-stage renal disease in Japanese children: a nationwide survey during 2006-2011.

Authors:  Motoshi Hattori; Mayumi Sako; Tetsuji Kaneko; Akira Ashida; Akira Matsunaga; Tohru Igarashi; Noritomo Itami; Toshiyuki Ohta; Yoshimitsu Gotoh; Kenichi Satomura; Masataka Honda; Takashi Igarashi
Journal:  Clin Exp Nephrol       Date:  2015-01-17       Impact factor: 2.801

7.  Renal replacement therapy in children: data from 12 registries in Europe.

Authors:  Bert J van der Heijden; Paul C W van Dijk; Kate Verrier-Jones; Kitty J Jager; J Douglas Briggs
Journal:  Pediatr Nephrol       Date:  2003-12-18       Impact factor: 3.714

Review 8.  Is there really an increase in non-minimal change nephrotic syndrome in children?

Authors:  Guido Filler; Elizabeth Young; Pavel Geier; Blair Carpenter; Alfred Drukker; Janusz Feber
Journal:  Am J Kidney Dis       Date:  2003-12       Impact factor: 8.860

9.  Frequency, etiology and treatment of childhood end-stage kidney disease in Australia and New Zealand.

Authors:  Nigel I T Orr; Stephen P McDonald; Steven McTaggart; Paul Henning; Jonathan C Craig
Journal:  Pediatr Nephrol       Date:  2009-04-17       Impact factor: 3.714

10.  Long-term survival of children with end-stage renal disease.

Authors:  Stephen P McDonald; Jonathan C Craig
Journal:  N Engl J Med       Date:  2004-06-24       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.